Source:http://linkedlifedata.com/resource/pubmed/id/11025376
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2001-1-4
|
pubmed:abstractText |
Chronic prostatic pain is still a diagnostic and therapeutic problem. The clinical observation that prostatic and pelvic pain is accompanied by motoric and sensoric disorders of the pelvic floor muscles led to the hypothesis that prostatic pain roots in a changed processing of afferent and efferent information with the central nervous system (CNS).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0302-2838
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
393-9
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:11025376-Adult,
pubmed-meshheading:11025376-Aged,
pubmed-meshheading:11025376-Botulinum Toxins, Type A,
pubmed-meshheading:11025376-Humans,
pubmed-meshheading:11025376-Injections,
pubmed-meshheading:11025376-Male,
pubmed-meshheading:11025376-Middle Aged,
pubmed-meshheading:11025376-Neuromuscular Agents,
pubmed-meshheading:11025376-Pain,
pubmed-meshheading:11025376-Prostate,
pubmed-meshheading:11025376-Urethra
|
pubmed:year |
2000
|
pubmed:articleTitle |
Perisphincteric injection of botulinum toxin type A. A treatment option for patients with chronic prostatic pain?
|
pubmed:affiliation |
Neurourology Unit, Department of Urology, University of Colorado Health Science Center, Denver, Colorado, USA. dh.zermann@med.uni-jena.de
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|